Abacavir and C. diff - a phase IV clinical study of FDA data

Summary:

C. diff is reported as a side effect among people who take Abacavir (abacavir sulfate), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Darunavir, and have Haemoglobin abnormal.

The phase IV clinical study analyzes which people have C. diff when taking Abacavir. It is created by eHealthMe based on reports of 8,281 people who have side effects when taking Abacavir from the FDA, and is updated regularly.

What is Abacavir?

Abacavir has active ingredients of abacavir sulfate. It is often used in hiv infection. eHealthMe is studying from 8,306 Abacavir users. Check the latest studies of Abacavir.

What is C. diff?

C. diff is found to be associated with 1,625 drugs and 1,768 conditions by eHealthMe. Check the latest studies of C. diff.

On Dec, 06, 2025

8,281 people reported to have side effects when taking Abacavir.
Among them, 10 people (0.12%) have C. diff.

Among these 10 people:

How long have people been on Abacavir when they have C. diff? *

What is the gender of people who have C. diff when taking Abacavir? *

female: 30 %
male: 70 %

What is the age of people who have C. diff when taking Abacavir? *

What are other drugs people take besides Abacavir? *

What are other side effects people have besides C. diff? *

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 5 people, 50.00%
Megacolon (a very dilated colon): 3 people, 30.00%
Diarrhea: 3 people, 30.00%
Pneumonia Aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree): 3 people, 30.00%
Cytomegalovirus Colitis (an inflammation of the colon from virus): 2 people, 20.00%
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung): 2 people, 20.00%
Hyperbilirubinaemia (excess of bilirubin in the blood): 2 people, 20.00%
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 2 people, 20.00%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 2 people, 20.00%
Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 2 people, 20.00%

What are the existing conditions these people have? *

Gastric Haemorrhage (bleeding stomach): 2 people, 20.00%
Gastric Ulcer (stomach ulcer): 2 people, 20.00%
Blood Magnesium Decreased: 2 people, 20.00%
Blood Potassium Decreased: 2 people, 20.00%
Burkitt Lymphoma (cancer of the lymphatic system): 2 people, 20.00%
Cancer Pain: 2 people, 20.00%
Cytomegalovirus Colitis (an inflammation of the colon from virus): 2 people, 20.00%
Fluid Imbalance (imbalance of fluid in body in intake and fluid lost): 2 people, 20.00%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 20.00%
Haemoglobin Abnormal: 2 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Abacavir and have C. diff?

- Check whether C. diff is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Abacavir:

Abacavir (8,306 reports)

C. diff treatments and more:

C. diff (13,844 reports)

Browse all side effects of Abacavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with C. diff:

C. diff (1,625 drugs)

Browse all the conditions that are associated with C. diff:

C. diff (1,768 conditions)

Drugs similar to Abacavir and C. diff :

How the study uses the data?

The study uses data from the FDA. It is based on abacavir sulfate (the active ingredients of Abacavir) and Abacavir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.